Showing results (1-10 of 190) with videos related to
Sort By:
Pageof 19
BMC Bioinformatics|March 20, 2008
Modelling the structures of G protein-coupled receptors aided by three-dimensional validationSiavoush Dastmalchi, W Bret Church, Michael B MorrisThe International Journal of Biochemistry & Cell Biology|August 12, 2008
Rhodopsin: structure, signal transduction and oligomerisationMichael B Morris, Siavoush Dastmalchi, W Bret ChurchAdvanced Drug Delivery Reviews|December 14, 2011
Structural modelling and dynamics of proteins for insights into drug interactionsTim Werner, Michael B Morris, Siavoush Dastmalchi, et al.The FEBS Journal|April 25, 2007
Prediction of rotational orientation of transmembrane helical segments of integral membrane proteins using new environment-based propensities for amino acids derived from structural analysesSiavoush Dastmalchi, Samira Beheshti, Michael B Morris, et al.Drug Discovery Today|October 10, 2021
A mechanistic perspective, clinical applications, and phage-display-assisted discovery of TNFα inhibitorsAli Akbar Alizadeh, Michael B Morris, W Bret Church, et al.Journal of Structural Biology|April 22, 2004
Presence of transient helical segments in the galanin-like peptide evident from (1)H NMR, circular dichroism, and prediction studiesSiavoush Dastmalchi, W Bret Church, Michael B Morris, et al.Drug Discovery Today|September 21, 2013
Phage display as a technology delivering on the promise of peptide drug discoveryMaryam Hamzeh-Mivehroud, Ali Akbar Alizadeh, Michael B Morris, et al.Cytokine & Growth Factor Reviews|March 23, 2019
Exploitation of phage display for the development of anti-cancer agents targeting fibroblast growth factor signaling pathways: New strategies to tackle an old challengeBehzad Jafari, Maryam Hamzeh-Mivehroud, Michael B Morris, et al.Advanced Pharmaceutical Bulletin|May 7, 2020
A QSAR Study on the 4-Substituted Coumarins as Potent Tubulin Polymerization InhibitorsLeila Dinparast, Siavoush DastmalchiCurrent Medicinal Chemistry|September 20, 2022
Recent Advances in Structural Modification Strategies for Lead Optimization of Tyrosine Kinase Inhibitors to Explore Novel Anticancer AgentsFereshteh Azimian, Siavoush DastmalchiPageof 19